111 related articles for article (PubMed ID: 8790951)
1. Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina.
Murakami Y; Ishinaga Y; Sano K; Murakami R; Kinoshita Y; Kitamura J; Kobayashi K; Okada S; Matsubara K; Shimada T; Morioka S
Clin Cardiol; 1996 Jun; 19(6):473-6. PubMed ID: 8790951
[TBL] [Abstract][Full Text] [Related]
2. Transcardiac 5-hydroxytryptamine release and impaired coronary endothelial function in patients with vasospastic angina.
Murakami Y; Shimada T; Ishinaga Y; Kinoshita Y; Kin H; Kitamura J; Ishibashi Y; Murakami R
Clin Exp Pharmacol Physiol; 1998 Dec; 25(12):999-1003. PubMed ID: 9887996
[TBL] [Abstract][Full Text] [Related]
3. Coronary spasm, prostaglandin and HLA factors.
Numano F; Aizawa T; Nomura S; Yajima M; Fujii J
Jpn Circ J; 1985 Jan; 49(1):119-27. PubMed ID: 3855470
[TBL] [Abstract][Full Text] [Related]
4. Impaired cardiac PGI2 and PGE2 biosynthesis in patients with angina pectoris.
Neri Serneri GG; Gensini GF; Abbate R; Prisco D; Rogasi PG; Castellani S; Casolo GC; Fazi A; Fantini F; Di Donato M
Am Heart J; 1986 Sep; 112(3):472-8. PubMed ID: 3529901
[TBL] [Abstract][Full Text] [Related]
5. [Continuous measurement of coronary sinus oxygen saturation in patients with effort angina and vasospastic angina].
Kikuchi F; Mikuniya A; Sawai M; Totsuka H; Tamura H; Chiba Y; Onodera K
J Cardiol; 1991; 21(4):857-68. PubMed ID: 1844441
[TBL] [Abstract][Full Text] [Related]
6. Increased cytosolic free Mg2+ and Ca2+ in platelets of patients with vasospastic angina.
Yoshimura M; Oshima T; Hiraga H; Nakano Y; Matsuura H; Yamagata T; Shiode N; Kato M; Kambe M; Kajiyama G
Am J Physiol; 1998 Feb; 274(2):R548-54. PubMed ID: 9486316
[TBL] [Abstract][Full Text] [Related]
7. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina.
Matsuyama K; Yasue H; Okumura K; Saito Y; Nakao K; Shirakami G; Imura H
Am J Cardiol; 1991 Oct; 68(10):991-5. PubMed ID: 1927939
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of plasma concentration of macrophage colony-stimulating factor in patients with vasospastic angina].
Tomimura M; Saitoh T; Kishida H; Kusama Y; Takano T
J Cardiol; 2002 Jan; 39(1):19-27. PubMed ID: 11828794
[TBL] [Abstract][Full Text] [Related]
10. Catecholamine release in coronary sinus during vasospastic angina induced by ergonovine.
Mezzetti A; Tomassetti V; Poggiopollini G; Ligabue A; Pecoraro F; Porreca E; Lapenna D; Cuccurullo F; Lenzi S
G Ital Cardiol; 1984 Dec; 14(12):1122-6. PubMed ID: 6532892
[TBL] [Abstract][Full Text] [Related]
11. [Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris].
Katayama N; Nakao K; Horiuchi K; Kasanuki H; Honda T
J Cardiol; 2005 Aug; 46(2):63-70. PubMed ID: 16127895
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
Odaka Y; Takahashi J; Tsuburaya R; Nishimiya K; Hao K; Matsumoto Y; Ito K; Sakata Y; Miyata S; Manita D; Hirowatari Y; Shimokawa H
Eur Heart J; 2017 Feb; 38(7):489-496. PubMed ID: 27694191
[TBL] [Abstract][Full Text] [Related]
13. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
Hung MJ; Hung MY; Cheng CW; Yang NI; Cherng WJ
Am J Med Sci; 2007 Sep; 334(3):160-7. PubMed ID: 17873528
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
Hung MJ; Cherng WJ; Cheng CW; Li LF
Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
[TBL] [Abstract][Full Text] [Related]
16. Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina.
Nishiyama K; Ogawa H; Yasue H; Soejima H; Misumi K; Kugiyama K; Tsuji I; Kumeda K
Thromb Res; 1998 Feb; 89(3):137-46. PubMed ID: 9622042
[TBL] [Abstract][Full Text] [Related]
17. Alcohol and coronary spasm.
Oda H; Suzuki M; Oniki T; Kishi Y; Numano F
Angiology; 1994 Mar; 45(3):187-97. PubMed ID: 8129199
[TBL] [Abstract][Full Text] [Related]
18. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease.
Hirsh PD; Firth BG; Campbell WB; Dehmer GJ; Willerson JT; Hillis LD
Am J Cardiol; 1983 Mar; 51(5):727-33. PubMed ID: 6829431
[TBL] [Abstract][Full Text] [Related]
19. Abnormal heart rate response to exercise in vasospastic angina: pathophysiologic mechanism in the provocation of coronary spasm.
Sato I; Shimomura K; Hasegawa Y; Ohe T; Matsuhisa M; Kamakura S; Haze K; Nakajima K
Am Heart J; 1984 Aug; 108(2):316-26. PubMed ID: 6464967
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of benidipine for vasospastic angina pectoris.
Suzuki H; Yokoyama K; Akimoto Y; Daida H
Arzneimittelforschung; 2007; 57(1):20-5. PubMed ID: 17341005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
